Insiders · Profile

Dockendorff Charles J

Director at Boston Scientific · Director at HAEMONETICS · Director at Keysight Technologies. Filing since 12 Feb 2016. CIK 0001400563

Company
Date
Role
Action
Shares
Amount
Of holding
7 May 2024
Director
Sold on a plan
3,946
$286.87K
100%
5 Sep 2023
Director
Sold on a plan
10,215
$895.65K
82.1%
18 Aug 2023
Director
Sold on a plan
17,079
$866.63K
81.2%
13 Dec 2022
Director
Sold, plan not stated
3,257
$602.75K
5.8%
4 Feb 2021
Director
Sold, plan not stated
12,180
$1.64M
47.0%
9 Jun 2017
Director
Bought
13,210
$499.47K
34.2%
12 Feb 2016
Director
Bought
30,000
$494.69K
259%
7 decisions on file.